Clik here to view.
インベンテージズのポートフォリオ企業コグノプティックスがアルツハイマー病の正確な診断能力を実証
ロンドン （ビジネスワイヤ） — インベンテージズは、ポートフォリオ企業の1つであるコグノプティックスが、アルツハイマー病をこれまでにない精度で診断できることを実証したと発表しました。SAPPHIRE II眼検査法を検討する多施設臨床試験において、感度85%、特異度95%で、アルツハイマー病患者と健常人(ボランティア)を判別できることが分かりました。...
View ArticleClik here to view.
Inventages 旗下投资组合公司Cognoptix展现精确诊断阿尔茨海默病的能力
伦敦 (美国商业资讯)–Inventages宣布其旗下投资组合公司Cognoptix已具备前所未有的阿尔茨海默病诊断精确度。一项针对SAPPHIRE II眼部测试进行的多站点临床试验显示，在区分阿尔茨海默病患者和健康志愿者时的灵敏度和特异性分别达85%和95%。...
View ArticleClik here to view.
Healios K.K. Announces 3 Billion JPY (USD $30.6 Million) Capital Raise
TOKYO Healios K.K. (Headquarters: Tokyo, Japan; President and CEO: Hardy TS Kagimoto M.D.), a Japanese bioventure company at the forefront of developing innovative therapies utilizing human induced...
View ArticleClik here to view.
pSivida Reports Complete Response Letter From FDA for ILUVIEN®
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today...
View ArticleClik here to view.
QImaging® Launches New optiMOS™ Scientific CMOS Camera
Smart Multimedia Gallery Featuring faster frame rates and lower noise, the optiMOS sCMOS Camera was designed as the higher performance, budget friendly CCD alternative (Photo: Business Wire) View...
View ArticleClik here to view.
Announcement of the Completion of Stage I and the Start of Enrollment for...
TOKYO R-Tech Ueno, Ltd. (JASDAQ:4573): We are now pleased to announce the completion of Stage I of the Phase I/II clinical trial (hereinafter called this trial) of recombinant human serum...
View ArticleClik here to view.
pSivida Corp. Reports FDA Labeling Discussions for ILUVIEN® for DME; Advisory...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee...
View ArticleClik here to view.
Menicon, Azabu University, and Yokohama City University Identify the Glaucoma...
NAGOYA, Japan Menicon announces that an article entitled, “Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk”, which presents the results of a study conducted by Menicon,...
View ArticleClik here to view.
Menicon、麻布大学和横滨市立大学发现犬类青光眼易感基因SRBD1
日本名古屋 (美国商业资讯)–Menicon宣布，一篇题为“犬类的青光眼风险易感基因SRBD1与人类相同”的论文已发表于科学期刊PLoS ONE，该论文呈报了Menicon、麻布大学和横滨市立大学开展的一项研究（以下称“该研究”）的结果。 Menicon与麻布大学和横滨市立大学合作开展的研究发现，日本柴犬的青光眼易感基因与人类相同。...
View ArticleClik here to view.
Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement
IRVINE, Calif. & SEOUL, South Korea Allergan, Inc., (NYSE: AGN) and Medytox, Inc. today announced that they have closed the license agreement which was previously announced on September 25,...
View ArticleClik here to view.
Akorn Acquires Betimol® from Santen
LAKE FOREST, Ill. Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today announced that it has acquired the NDA and all rights to Betimol® (timolol ophthalmic solution) 0.25%...
View ArticleClik here to view.
pSivida Corp. Reports First Orders for ILUVIEN® Shipped for U.K. National...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee...
View ArticleClik here to view.
Menicon Realizes Bold Vision in the Netherlands
Smart Multimedia Gallery Emmen Mayor Cees Bijl, Menicon CEO Hidenari Tanaka and Japanese diplomat Yutaka Kikuta cut the ceremonial ribbon to open Menicon’s new facility at Emmen, the Netherlands....
View ArticleClik here to view.
Menicon在荷兰实现重大愿景
Smart Multimedia Gallery Emmen Mayor Cees Bijl, Menicon CEO Hidenari Tanaka and Japanese diplomat Yutaka Kikuta cut the ceremonial ribbon to open Menicon’s new facility at Emmen, the Netherlands....
View ArticleClik here to view.
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno...
TOKYO Investment Bridge, one of Japan’s leading independent IR services companies, has released a “Bridge Report” on R-Tech Ueno, Ltd. (JASDAQ:4573) reviewing the results for the first half and...
View ArticleClik here to view.
Hoya Announces Third Quarter Financial Results Under IFRS
TOKYO Hoya Corporation (TOKYO:7741) today announced financial results for the third quarter ended December 31, 2013. The full reports are available at: http://www.hoya.com/investor/ During the...
View ArticleClik here to view.
Mitsui Chemicals Announces World’s First Large Scale XDI Plant
Smart Multimedia Gallery Mitsui Chemicals is the world top share opthalmic lens monomers supplier (Photo: Business Wire) View and Share Photo Download Small TOKYO Mitsui Chemicals...
View ArticleClik here to view.
三井化学宣布建造世界首座大规模XDI工厂
Smart Multimedia Gallery Mitsui Chemicals is the world top share opthalmic lens monomers supplier (Photo: Business Wire) View and Share Photo Download Small 东京 (美国商业资讯)–三井化学(Mitsui Chemicals,...
View ArticleClik here to view.
pSivida Corp. Reports Second Quarter 2014 Results
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for...
View ArticleClik here to view.
R-Tech Ueno: Notice of Revisions of Dividend Forecast
TOKYO R-Tech Ueno, Ltd. (JASDAQ:4573): A resolution was passed during the Board of Directors’ Meeting held on February 12, 2014 to revise our dividend per share forecast as described below. 1....
View Article